United States Biotechnology & Medical Research

Latigo Biotherapeutics Inc (LTGO)

Track

Latigo Biotherapeutics Inc. recorded two significant insider purchases on August 10, 2026. Foresite Capital Management V, LLC and James B. Tananbaum each acquired shares valued at $2.52 million. These transactions represent a total buy volume of $5.04 million, occurring amidst a 3.1% stock price increase over the preceding ninety-day period.

No insider activity signal

Not featured in screeners

Featured in screeners

No insider activity signal

Not featured in screeners

Ticker: LTGO

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Insider activity signals

0 activity signals detected for Latigo Biotherapeutics Inc

No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

3.4

Foresite Capital Management V, LLC Large shareholder

Transaction date 10 Aug 2026

Purchase

Price

471.30

Quantity 89,627 -39.0%

Value US$972,291

Comments Filing

4.0

Tananbaum James B. Non-Executive Director Large shareholder

Transaction date 10 Aug 2026

Purchase

Price

281.28

Quantity 76,382 -49.2%

Value US$445,772

Comments Filing

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value	Details
2026-08-10	2026-08-10	B Purchase	3.4 Foresite Capital Management V, LLC Large shareholder	89,627 -39.0% 471.30 US$972,291	89,627 -39.0%	471.30	US$972,291
2026-08-10	2026-08-10	B Purchase	4.0 Tananbaum James B. Non-Executive Director Large shareholder	76,382 -49.2% 281.28 US$445,772	76,382 -49.2%	281.28	US$445,772